Disclosures for "Disparities in Healthcare Interactions After Intracerebral Hemorrhage: Evidence from the REDUCE Trial"
-
Ms. Zabinska has nothing to disclose.
-
Mr. Taylor has nothing to disclose.
-
Miss Peasley has nothing to disclose.
-
Mr. Lalwani has nothing to disclose.
-
Ms. Schwartz has nothing to disclose.
-
The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
-
Dr. Sansing has nothing to disclose.
-
The institution of Dr. Arora has received research support from Bayer.
-
Dr. Mena-Hurtado has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cook. Dr. Mena-Hurtado has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Mena-Hurtado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Penumbra. Dr. Mena-Hurtado has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for legal review.
-
Dr. De Havenon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has stock in Certus. Dr. De Havenon has stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
-
Ms. Okpala has nothing to disclose.
-
Dr. Bushnell has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ZZ Biotech. The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from AHRQ. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care.
-
Dr. Mullen has received publishing royalties from a publication relating to health care.
-
Jordana Cohen has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley Online Library (Pharmacoepidemiology and Drug Safety). The institution of Jordana Cohen has received research support from NIH-NHLBI.
-
An immediate family member of DEBBIE Cohen has received stock or an ownership interest from incyte.
-
Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Terumo. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WL Gore. The institution of Dr. Messe has received research support from WL Gore. The institution of Dr. Messe has received research support from Mallinkrodt. The institution of Dr. Messe has received research support from Biogen. Dr. Messe has received intellectual property interests from a discovery or technology relating to health care. Dr. Messe has received publishing royalties from a publication relating to health care. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving as a Clinical Event Committee for the CONFORMAL left atrial appendage occlusion trial with Yale Cardiovascular Research Group.
-
Dr. Forman has nothing to disclose.
-
Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.